Clinical significance of energy loss index in patients with low-gradient severe aortic stenosis and preserved ejection fraction.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 06 04 2019
revised: 31 07 2019
accepted: 10 01 2020
pubmed: 8 2 2020
medline: 29 6 2021
entrez: 8 2 2020
Statut: ppublish

Résumé

We hypothesized that among patients with low-gradient severe aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF), reclassification of AS severity as moderate by pressure recovery adjusted indexed aortic valve area (AVAi) = energy loss index (ELI), may identify a subgroup of patients with a better outcome. Three hundred and seventy-nine patients with low-gradient AS (defined by AVAi ≤ 0.6 cm2/m2 and mean aortic pressure gradient < 40 mmHg) and preserved LVEF ≥50% were studied. Reclassification as moderate AS by ELI was defined as AVAi ≤0.6 cm2/m2 but with an ELI >0.6 cm2/m2. Cardiac events [cardiac mortality and/or need for aortic valve replacement (AVR)] during follow-up were studied. One hundred and forty-eight patients (39%) were reclassified as moderate AS by ELI. Reclassification as moderate AS was independently associated with decreased body surface area, normal flow status, decreased left ventricular mass index, and left atrial volume index (all P < 0.05). After adjustment for variables of prognostic interest, reclassification as moderate AS by ELI was associated with a considerable reduction of risk of cardiac events {adjusted hazard ratio (HR) 0.49 [95% confidence interval (CI) 0.33-0.72]; P < 0.001}, need for AVR [adjusted HR 0.52 (95% CI 0.34-0.81); P = 0.004], and cardiac mortality [adjusted HR 0.46 (95% CI 0.22-0.98); P = 0.044]. In patients with low-gradient severe AS and preserved LVEF, calculation of ELI permits to reclassify almost 40% of patients as having moderate AS. These reclassified patients have a considerable reduction of the risk of cardiac events during follow-up. Calculation of ELI is useful for decision-making in patients with low-gradient severe AS and preserved ejection fraction.

Identifiants

pubmed: 32031603
pii: 5730221
doi: 10.1093/ehjci/jeaa010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

608-615

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Alexandre Altes (A)

Cardiology Department, Echocardiography Laboratory, Heart Valve Center, GCS-Groupement des Hôpitaux de l'Institut Catholique Lillois/Faculté de médecine et de maïeutique, UCLille, Rue du Grand But - BP 249 59462 Lomme Cedex, France.

Anne Ringle (A)

Cardiology Department, Echocardiography Laboratory, Heart Valve Center, GCS-Groupement des Hôpitaux de l'Institut Catholique Lillois/Faculté de médecine et de maïeutique, UCLille, Rue du Grand But - BP 249 59462 Lomme Cedex, France.

Yohann Bohbot (Y)

Cardiology Department, Centre Hospitalier Universitaire d'Amiens, Avenue Rene Laennec, 80054 Amiens Cedex 1, France.

Océane Bouchot (O)

Cardiology Department, Centre Hospitalier Universitaire de Grenoble, Avenue Maquis du Grésivaudan, 38700 La Tronche, France.

Ludovic Appert (L)

Cardiology Department, Echocardiography Laboratory, Heart Valve Center, GCS-Groupement des Hôpitaux de l'Institut Catholique Lillois/Faculté de médecine et de maïeutique, UCLille, Rue du Grand But - BP 249 59462 Lomme Cedex, France.

Raphaëlle A Guerbaai (RA)

Department Public Health (DPH), Faculty of Medicine, University of Basel, Petersplatz 10, 4051 Basel, Switzerland.

Mesut Gun (M)

Cardiology Department, Centre Hospitalier Universitaire d'Amiens, Avenue Rene Laennec, 80054 Amiens Cedex 1, France.

Pierre Vladimir Ennezat (PV)

Cardiology Department, Centre Hospitalier Universitaire de Grenoble, Avenue Maquis du Grésivaudan, 38700 La Tronche, France.

Christophe Tribouilloy (C)

Cardiology Department, Centre Hospitalier Universitaire d'Amiens, Avenue Rene Laennec, 80054 Amiens Cedex 1, France.
UR UPJV 7517, CURS-UFR de pharmacie, Laboratoire UPJCV, Université de Picardie, 1 chemin du Thil, 80000 Amiens, France.

Sylvestre Maréchaux (S)

Cardiology Department, Echocardiography Laboratory, Heart Valve Center, GCS-Groupement des Hôpitaux de l'Institut Catholique Lillois/Faculté de médecine et de maïeutique, UCLille, Rue du Grand But - BP 249 59462 Lomme Cedex, France.
UR UPJV 7517, CURS-UFR de pharmacie, Laboratoire UPJCV, Université de Picardie, 1 chemin du Thil, 80000 Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH